Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Drug Safety Crisis Response My Core Decision I will recommend full, proactive disclosure. Waiting is not a viable option. Here's why: Every day of delay adds approximately 22 patients exposed to an undisclosed risk Regulatory agencies treat delayed voluntary disclosure far more favorably than…Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer